[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Biologics and Biosimilars Market Report 2018

March 2018 | 112 pages | ID: A959479A32BQEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Biologics and Biosimilars market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Biologics and Biosimilars for these regions, from 2013 to 2025 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Biologics and Biosimilars market competition by top manufacturers/players, with Biologics and Biosimilars sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Pfizer
  • Roche
  • Amgen
  • AbbVie
  • Sanofi
  • Johnson & Johnson
  • Novo Nordisk
  • Novartis
  • Merck
  • Lilly
  • 3sbio
  • Changchun High Tech
  • CP Guojian Pharmacy
  • Biotech Pharma
  • Gelgen Biopharma
  • Sandoz
  • Teva
  • Hospira
  • Mylan
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • Antibiotic
  • Enzyme
  • Hormone
  • Non-Patented Biological Reagents
  • Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Tumor
  • Diabetes
  • Cardiovascular
  • Hemophilia
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Biologics and Biosimilars Market Report 2018

1 BIOLOGICS AND BIOSIMILARS OVERVIEW

1.1 Product Overview and Scope of Biologics and Biosimilars
1.2 Classification of Biologics and Biosimilars by Product Category
  1.2.1 Asia-Pacific Biologics and Biosimilars Market Size (Sales) Comparison by Types (2013-2025)
  1.2.2 Asia-Pacific Biologics and Biosimilars Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Antibiotic
  1.2.4 Enzyme
  1.2.5 Hormone
  1.2.6 Non-Patented Biological Reagents
  1.2.7 Other
1.3 Asia-Pacific Biologics and Biosimilars Market by Application/End Users
  1.3.1 Asia-Pacific Biologics and Biosimilars Sales (Volume) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Tumor
  1.3.3 Diabetes
  1.3.4 Cardiovascular
  1.3.5 Hemophilia
  1.3.6 Other
1.4 Asia-Pacific Biologics and Biosimilars Market by Region
  1.4.1 Asia-Pacific Biologics and Biosimilars Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 China Status and Prospect (2013-2025)
  1.4.3 Japan Status and Prospect (2013-2025)
  1.4.4 South Korea Status and Prospect (2013-2025)
  1.4.5 Taiwan Status and Prospect (2013-2025)
  1.4.6 India Status and Prospect (2013-2025)
  1.4.7 Southeast Asia Status and Prospect (2013-2025)
  1.4.8 Australia Status and Prospect (2013-2025)
1.5 Asia-Pacific Market Size (Value and Volume) of Biologics and Biosimilars (2013-2025)
  1.5.1 Asia-Pacific Biologics and Biosimilars Sales and Growth Rate (2013-2025)
  1.5.2 Asia-Pacific Biologics and Biosimilars Revenue and Growth Rate (2013-2025)

2 ASIA-PACIFIC BIOLOGICS AND BIOSIMILARS COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Biologics and Biosimilars Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Biologics and Biosimilars Sales Volume and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Asia-Pacific Biologics and Biosimilars Revenue and Share by Players/Suppliers (2013-2018)
2.2 Asia-Pacific Biologics and Biosimilars (Volume and Value) by Type
  2.2.1 Asia-Pacific Biologics and Biosimilars Sales and Market Share by Type (2013-2018)
  2.2.2 Asia-Pacific Biologics and Biosimilars Revenue and Market Share by Type (2013-2018)
2.3 Asia-Pacific Biologics and Biosimilars (Volume) by Application
2.4 Asia-Pacific Biologics and Biosimilars (Volume and Value) by Region
  2.4.1 Asia-Pacific Biologics and Biosimilars Sales and Market Share by Region (2013-2018)
  2.4.2 Asia-Pacific Biologics and Biosimilars Revenue and Market Share by Region (2013-2018)

3 CHINA BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

3.1 China Biologics and Biosimilars Sales and Value (2013-2018)
  3.1.1 China Biologics and Biosimilars Sales Volume and Growth Rate (2013-2018)
  3.1.2 China Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
  3.1.3 China Biologics and Biosimilars Sales Price Trend (2013-2018)
3.2 China Biologics and Biosimilars Sales Volume and Market Share by Type
3.3 China Biologics and Biosimilars Sales Volume and Market Share by Application

4 JAPAN BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Biologics and Biosimilars Sales and Value (2013-2018)
  4.1.1 Japan Biologics and Biosimilars Sales Volume and Growth Rate (2013-2018)
  4.1.2 Japan Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
  4.1.3 Japan Biologics and Biosimilars Sales Price Trend (2013-2018)
4.2 Japan Biologics and Biosimilars Sales Volume and Market Share by Type
4.3 Japan Biologics and Biosimilars Sales Volume and Market Share by Application

5 SOUTH KOREA BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Biologics and Biosimilars Sales and Value (2013-2018)
  5.1.1 South Korea Biologics and Biosimilars Sales Volume and Growth Rate (2013-2018)
  5.1.2 South Korea Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
  5.1.3 South Korea Biologics and Biosimilars Sales Price Trend (2013-2018)
5.2 South Korea Biologics and Biosimilars Sales Volume and Market Share by Type
5.3 South Korea Biologics and Biosimilars Sales Volume and Market Share by Application

6 TAIWAN BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Biologics and Biosimilars Sales and Value (2013-2018)
  6.1.1 Taiwan Biologics and Biosimilars Sales Volume and Growth Rate (2013-2018)
  6.1.2 Taiwan Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
  6.1.3 Taiwan Biologics and Biosimilars Sales Price Trend (2013-2018)
6.2 Taiwan Biologics and Biosimilars Sales Volume and Market Share by Type
6.3 Taiwan Biologics and Biosimilars Sales Volume and Market Share by Application

7 INDIA BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

7.1 India Biologics and Biosimilars Sales and Value (2013-2018)
  7.1.1 India Biologics and Biosimilars Sales Volume and Growth Rate (2013-2018)
  7.1.2 India Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
  7.1.3 India Biologics and Biosimilars Sales Price Trend (2013-2018)
7.2 India Biologics and Biosimilars Sales Volume and Market Share by Type
7.3 India Biologics and Biosimilars Sales Volume and Market Share by Application

8 SOUTHEAST ASIA BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Biologics and Biosimilars Sales and Value (2013-2018)
  8.1.1 Southeast Asia Biologics and Biosimilars Sales Volume and Growth Rate (2013-2018)
  8.1.2 Southeast Asia Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
  8.1.3 Southeast Asia Biologics and Biosimilars Sales Price Trend (2013-2018)
8.2 Southeast Asia Biologics and Biosimilars Sales Volume and Market Share by Type
8.3 Southeast Asia Biologics and Biosimilars Sales Volume and Market Share by Application

9 AUSTRALIA BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Biologics and Biosimilars Sales and Value (2013-2018)
  9.1.1 Australia Biologics and Biosimilars Sales Volume and Growth Rate (2013-2018)
  9.1.2 Australia Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
  9.1.3 Australia Biologics and Biosimilars Sales Price Trend (2013-2018)
9.2 Australia Biologics and Biosimilars Sales Volume and Market Share by Type
9.3 Australia Biologics and Biosimilars Sales Volume and Market Share by Application

10 ASIA-PACIFIC BIOLOGICS AND BIOSIMILARS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Pfizer
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Biologics and Biosimilars Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  10.1.4 Main Business/Business Overview
10.2 Roche
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Biologics and Biosimilars Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  10.2.4 Main Business/Business Overview
10.3 Amgen
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Biologics and Biosimilars Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  10.3.4 Main Business/Business Overview
10.4 AbbVie
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Biologics and Biosimilars Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  10.4.4 Main Business/Business Overview
10.5 Sanofi
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Biologics and Biosimilars Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Sanofi Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  10.5.4 Main Business/Business Overview
10.6 Johnson & Johnson
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Biologics and Biosimilars Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  10.6.4 Main Business/Business Overview
10.7 Novo Nordisk
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Biologics and Biosimilars Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  10.7.4 Main Business/Business Overview
10.8 Novartis
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Biologics and Biosimilars Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  10.8.4 Main Business/Business Overview
10.9 Merck
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Biologics and Biosimilars Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Merck Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  10.9.4 Main Business/Business Overview
10.10 Lilly
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Biologics and Biosimilars Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Lilly Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  10.10.4 Main Business/Business Overview
10.11 3sbio
10.12 Changchun High Tech
10.13 CP Guojian Pharmacy
10.14 Biotech Pharma
10.15 Gelgen Biopharma
10.16 Sandoz
10.17 Teva
10.18 Hospira
10.19 Mylan

11 BIOLOGICS AND BIOSIMILARS MANUFACTURING COST ANALYSIS

11.1 Biologics and Biosimilars Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Biologics and Biosimilars

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Biologics and Biosimilars Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2017
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC BIOLOGICS AND BIOSIMILARS MARKET FORECAST (2018-2025)

15.1 Asia-Pacific Biologics and Biosimilars Sales Volume, Revenue and Price Forecast (2018-2025)
  15.1.1 Asia-Pacific Biologics and Biosimilars Sales Volume and Growth Rate Forecast (2018-2025)
  15.1.2 Asia-Pacific Biologics and Biosimilars Revenue and Growth Rate Forecast (2018-2025)
  15.1.3 Asia-Pacific Biologics and Biosimilars Price and Trend Forecast (2018-2025)
15.2 Asia-Pacific Biologics and Biosimilars Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.1 Asia-Pacific Biologics and Biosimilars Sales Volume and Growth Rate Forecast by Region (2018-2025)
  15.2.2 Asia-Pacific Biologics and Biosimilars Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.3 China Biologics and Biosimilars Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.4 Japan Biologics and Biosimilars Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.5 South Korea Biologics and Biosimilars Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.6 Taiwan Biologics and Biosimilars Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.7 India Biologics and Biosimilars Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.8 Southeast Asia Biologics and Biosimilars Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.9 Australia Biologics and Biosimilars Sales, Revenue and Growth Rate Forecast (2018-2025)
15.3 Asia-Pacific Biologics and Biosimilars Sales, Revenue and Price Forecast by Type (2018-2025)
  15.3.1 Asia-Pacific Biologics and Biosimilars Sales Forecast by Type (2018-2025)
  15.3.2 Asia-Pacific Biologics and Biosimilars Revenue Forecast by Type (2018-2025)
  15.3.3 Asia-Pacific Biologics and Biosimilars Price Forecast by Type (2018-2025)
15.4 Asia-Pacific Biologics and Biosimilars Sales Forecast by Application (2018-2025)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Biologics and Biosimilars
Figure Asia-Pacific Biologics and Biosimilars Sales Volume (K Units) by Type (2013-2025)
Figure Asia-Pacific Biologics and Biosimilars Sales Volume Market Share by Type (Product Category) in 2017
Figure Antibiotic Product Picture
Figure Enzyme Product Picture
Figure Hormone Product Picture
Figure Non-Patented Biological Reagents Product Picture
Figure Other Product Picture
Figure Asia-Pacific Biologics and Biosimilars Sales (K Units) by Application (2013-2025)
Figure Asia-Pacific Sales Market Share of Biologics and Biosimilars by Application in 2017
Figure Tumor Examples
Table Key Downstream Customer in Tumor
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Cardiovascular Examples
Table Key Downstream Customer in Cardiovascular
Figure Hemophilia Examples
Table Key Downstream Customer in Hemophilia
Figure Other Examples
Table Key Downstream Customer in Other
Figure Asia-Pacific Biologics and Biosimilars Market Size (Million USD) by Region (2013-2025)
Figure China Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure South Korea Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Taiwan Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Australia Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Biologics and Biosimilars Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Asia-Pacific Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Biologics and Biosimilars Market Major Players Product Sales Volume (K Units)(2013-2018)
Table Asia-Pacific Biologics and Biosimilars Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Asia-Pacific Biologics and Biosimilars Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Biologics and Biosimilars Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Biologics and Biosimilars Sales Share by Players/Suppliers
Figure Asia-Pacific Biologics and Biosimilars Market Major Players Product Revenue (Million USD) 2013-2018
Table Asia-Pacific Biologics and Biosimilars Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Asia-Pacific Biologics and Biosimilars Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Biologics and Biosimilars Revenue Share by Players
Figure 2017 Asia-Pacific Biologics and Biosimilars Revenue Share by Players
Table Asia-Pacific Biologics and Biosimilars Sales and Market Share by Type (2013-2018)
Table Asia-Pacific Biologics and Biosimilars Sales Share by Type (2013-2018)
Figure Sales Market Share of Biologics and Biosimilars by Type (2013-2018)
Figure Asia-Pacific Biologics and Biosimilars Sales Growth Rate by Type (2013-2018)
Table Asia-Pacific Biologics and Biosimilars Revenue (Million USD) and Market Share by Type (2013-2018)
Table Asia-Pacific Biologics and Biosimilars Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Biologics and Biosimilars by Type (2013-2018)
Figure Asia-Pacific Biologics and Biosimilars Revenue Growth Rate by Type (2013-2018)
Table Asia-Pacific Biologics and Biosimilars Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Asia-Pacific Biologics and Biosimilars Sales Share by Region (2013-2018)
Figure Sales Market Share of Biologics and Biosimilars by Region (2013-2018)
Figure Asia-Pacific Biologics and Biosimilars Sales Market Share by Region in 2017
Table Asia-Pacific Biologics and Biosimilars Revenue (Million USD) and Market Share by Region (2013-2018)
Table Asia-Pacific Biologics and Biosimilars Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Biologics and Biosimilars by Region (2013-2018)
Figure Asia-Pacific Biologics and Biosimilars Revenue Market Share by Region in 2017
Table Asia-Pacific Biologics and Biosimilars Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Asia-Pacific Biologics and Biosimilars Sales Share (%) by Application (2013-2018)
Figure Asia-Pacific Biologics and Biosimilars Sales Market Share by Application (2013-2018)
Figure Asia-Pacific Biologics and Biosimilars Sales Market Share by Application (2013-2018)
Figure China Biologics and Biosimilars Sales (K Units) and Growth Rate (2013-2018)
Figure China Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Biologics and Biosimilars Sales Price (USD/Unit) Trend (2013-2018)
Table China Biologics and Biosimilars Sales Volume (K Units) by Type (2013-2018)
Table China Biologics and Biosimilars Sales Volume Market Share by Type (2013-2018)
Figure China Biologics and Biosimilars Sales Volume Market Share by Type in 2017
Table China Biologics and Biosimilars Sales Volume (K Units) by Applications (2013-2018)
Table China Biologics and Biosimilars Sales Volume Market Share by Application (2013-2018)
Figure China Biologics and Biosimilars Sales Volume Market Share by Application in 2017
Figure Japan Biologics and Biosimilars Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Biologics and Biosimilars Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Biologics and Biosimilars Sales Volume (K Units) by Type (2013-2018)
Table Japan Biologics and Biosimilars Sales Volume Market Share by Type (2013-2018)
Figure Japan Biologics and Biosimilars Sales Volume Market Share by Type in 2017
Table Japan Biologics and Biosimilars Sales Volume (K Units) by Applications (2013-2018)
Table Japan Biologics and Biosimilars Sales Volume Market Share by Application (2013-2018)
Figure Japan Biologics and Biosimilars Sales Volume Market Share by Application in 2017
Figure South Korea Biologics and Biosimilars Sales (K Units) and Growth Rate (2013-2018)
Figure South Korea Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
Figure South Korea Biologics and Biosimilars Sales Price (USD/Unit) Trend (2013-2018)
Table South Korea Biologics and Biosimilars Sales Volume (K Units) by Type (2013-2018)
Table South Korea Biologics and Biosimilars Sales Volume Market Share by Type (2013-2018)
Figure South Korea Biologics and Biosimilars Sales Volume Market Share by Type in 2017
Table South Korea Biologics and Biosimilars Sales Volume (K Units) by Applications (2013-2018)
Table South Korea Biologics and Biosimilars Sales Volume Market Share by Application (2013-2018)
Figure South Korea Biologics and Biosimilars Sales Volume Market Share by Application in 2017
Figure Taiwan Biologics and Biosimilars Sales (K Units) and Growth Rate (2013-2018)
Figure Taiwan Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
Figure Taiwan Biologics and Biosimilars Sales Price (USD/Unit) Trend (2013-2018)
Table Taiwan Biologics and Biosimilars Sales Volume (K Units) by Type (2013-2018)
Table Taiwan Biologics and Biosimilars Sales Volume Market Share by Type (2013-2018)
Figure Taiwan Biologics and Biosimilars Sales Volume Market Share by Type in 2017
Table Taiwan Biologics and Biosimilars Sales Volume (K Units) by Applications (2013-2018)
Table Taiwan Biologics and Biosimilars Sales Volume Market Share by Application (2013-2018)
Figure Taiwan Biologics and Biosimilars Sales Volume Market Share by Application in 2017
Figure India Biologics and Biosimilars Sales (K Units) and Growth Rate (2013-2018)
Figure India Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Biologics and Biosimilars Sales Price (USD/Unit) Trend (2013-2018)
Table India Biologics and Biosimilars Sales Volume (K Units) by Type (2013-2018)
Table India Biologics and Biosimilars Sales Volume Market Share by Type (2013-2018)
Figure India Biologics and Biosimilars Sales Volume Market Share by Type in 2017
Table India Biologics and Biosimilars Sales Volume (K Units) by Application (2013-2018)
Table India Biologics and Biosimilars Sales Volume Market Share by Application (2013-2018)
Figure India Biologics and Biosimilars Sales Volume Market Share by Application in 2017
Figure Southeast Asia Biologics and Biosimilars Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Biologics and Biosimilars Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Biologics and Biosimilars Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Biologics and Biosimilars Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Biologics and Biosimilars Sales Volume Market Share by Type in 2017
Table Southeast Asia Biologics and Biosimilars Sales Volume (K Units) by Applications (2013-2018)
Table Southeast Asia Biologics and Biosimilars Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Biologics and Biosimilars Sales Volume Market Share by Application in 2017
Figure Australia Biologics and Biosimilars Sales (K Units) and Growth Rate (2013-2018)
Figure Australia Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
Figure Australia Biologics and Biosimilars Sales Price (USD/Unit) Trend (2013-2018)
Table Australia Biologics and Biosimilars Sales Volume (K Units) by Type (2013-2018)
Table Australia Biologics and Biosimilars Sales Volume Market Share by Type (2013-2018)
Figure Australia Biologics and Biosimilars Sales Volume Market Share by Type in 2017
Table Australia Biologics and Biosimilars Sales Volume (K Units) by Applications (2013-2018)
Table Australia Biologics and Biosimilars Sales Volume Market Share by Application (2013-2018)
Figure Australia Biologics and Biosimilars Sales Volume Market Share by Application in 2017
Table Pfizer Biologics and Biosimilars Basic Information List
Table Pfizer Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Biologics and Biosimilars Sales (K Units) and Growth Rate (2013-2018)
Figure Pfizer Biologics and Biosimilars Sales Market Share in Asia-Pacific (2013-2018)
Figure Pfizer Biologics and Biosimilars Revenue Market Share in Asia-Pacific (2013-2018)
Table Roche Biologics and Biosimilars Basic Information List
Table Roche Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Roche Biologics and Biosimilars Sales (K Units) and Growth Rate (2013-2018)
Figure Roche Biologics and Biosimilars Sales Market Share in Asia-Pacific (2013-2018)
Figure Roche Biologics and Biosimilars Revenue Market Share in Asia-Pacific (2013-2018)
Table Amgen Biologics and Biosimilars Basic Information List
Table Amgen Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen Biologics and Biosimilars Sales (K Units) and Growth Rate (2013-2018)
Figure Amgen Biologics and Biosimilars Sales Market Share in Asia-Pacific (2013-2018)
Figure Amgen Biologics and Biosimilars Revenue Market Share in Asia-Pacific (2013-2018)
Table AbbVie Biologics and Biosimilars Basic Information List
Table AbbVie Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AbbVie Biologics and Biosimilars Sales (K Units) and Growth Rate (2013-2018)
Figure AbbVie Biologics and Biosimilars Sales Market Share in Asia-Pacific (2013-2018)
Figure AbbVie Biologics and Biosimilars Revenue Market Share in Asia-Pacific (2013-2018)
Table Sanofi Biologics and Biosimilars Basic Information List
Table Sanofi Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Biologics and Biosimilars Sales (K Units) and Growth Rate (2013-2018)
Figure Sanofi Biologics and Biosimilars Sales Market Share in Asia-Pacific (2013-2018)
Figure Sanofi Biologics and Biosimilars Revenue Market Share in Asia-Pacific (2013-2018)
Table Johnson & Johnson Biologics and Biosimilars Basic Information List
Table Johnson & Johnson Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson Biologics and Biosimilars Sales (K Units) and Growth Rate (2013-2018)
Figure Johnson & Johnson Biologics and Biosimilars Sales Market Share in Asia-Pacific (2013-2018)
Figure Johnson & Johnson Biologics and Biosimilars Revenue Market Share in Asia-Pacific (2013-2018)
Table Novo Nordisk Biologics and Biosimilars Basic Information List
Table Novo Nordisk Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novo Nordisk Biologics and Biosimilars Sales (K Units) and Growth Rate (2013-2018)
Figure Novo Nordisk Biologics and Biosimilars Sales Market Share in Asia-Pacific (2013-2018)
Figure Novo Nordisk Biologics and Biosimilars Revenue Market Share in Asia-Pacific (2013-2018)
Table Novartis Biologics and Biosimilars Basic Information List
Table Novartis Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Biologics and Biosimilars Sales (K Units) and Growth Rate (2013-2018)
Figure Novartis Biologics and Biosimilars Sales Market Share in Asia-Pacific (2013-2018)
Figure Novartis Biologics and Biosimilars Revenue Market Share in Asia-Pacific (2013-2018)
Table Merck Biologics and Biosimilars Basic Information List
Table Merck Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck Biologics and Biosimilars Sales (K Units) and Growth Rate (2013-2018)
Figure Merck Biologics and Biosimilars Sales Market Share in Asia-Pacific (2013-2018)
Figure Merck Biologics and Biosimilars Revenue Market Share in Asia-Pacific (2013-2018)
Table Lilly Biologics and Biosimilars Basic Information List
Table Lilly Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Lilly Biologics and Biosimilars Sales (K Units) and Growth Rate (2013-2018)
Figure Lilly Biologics and Biosimilars Sales Market Share in Asia-Pacific (2013-2018)
Figure Lilly Biologics and Biosimilars Revenue Market Share in Asia-Pacific (2013-2018)
Table 3sbio Biologics and Biosimilars Basic Information List
Table Changchun High Tech Biologics and Biosimilars Basic Information List
Table CP Guojian Pharmacy Biologics and Biosimilars Basic Information List
Table Biotech Pharma Biologics and Biosimilars Basic Information List
Table Gelgen Biopharma Biologics and Biosimilars Basic Information List
Table Sandoz Biologics and Biosimilars Basic Information List
Table Teva Biologics and Biosimilars Basic Information List
Table Hospira Biologics and Biosimilars Basic Information List
Table Mylan Biologics and Biosimilars Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologics and Biosimilars
Figure Manufacturing Process Analysis of Biologics and Biosimilars
Figure Biologics and Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2017
Table Major Buyers of Biologics and Biosimilars
Table Distributors/Traders List
Figure Asia-Pacific Biologics and Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Biologics and Biosimilars Price (USD/Unit) and Trend Forecast (2018-2025)
Table Asia-Pacific Biologics and Biosimilars Sales Volume (K Units) Forecast by Region (2018-2025)
Figure Asia-Pacific Biologics and Biosimilars Sales Volume Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Biologics and Biosimilars Sales Volume Market Share Forecast by Region in 2025
Table Asia-Pacific Biologics and Biosimilars Revenue (Million USD) Forecast by Region (2018-2025)
Figure Asia-Pacific Biologics and Biosimilars Revenue Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Biologics and Biosimilars Revenue Market Share Forecast by Region in 2025
Figure China Biologics and Biosimilars Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure China Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Biologics and Biosimilars Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure South Korea Biologics and Biosimilars Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure South Korea Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Taiwan Biologics and Biosimilars Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure Taiwan Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Biologics and Biosimilars Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure India Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Biologics and Biosimilars Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Australia Biologics and Biosimilars Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure Australia Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Biologics and Biosimilars Sales (K Units) Forecast by Type (2018-2025)
Figure Asia-Pacific Biologics and Biosimilars Sales Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Biologics and Biosimilars Revenue (Million USD) Forecast by Type (2018-2025)
Figure Asia-Pacific Biologics and Biosimilars Revenue Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Biologics and Biosimilars Price (USD/Unit) Forecast by Type (2018-2025)
Table Asia-Pacific Biologics and Biosimilars Sales (K Units) Forecast by Application (2018-2025)
Figure Asia-Pacific Biologics and Biosimilars Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories